HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SCCS OKs Preservative PHMB At 0.1%, Leaving Room For EU Cosmetic Use

This article was originally published in The Rose Sheet

Executive Summary

European NGOs have been clamoring for a ban on the use of preservative polyaminopropyl biguanide in cosmetics due to its listing under EU regs as potentially carcinogenic, mutagenic or reprotoxic. The Scientific Committee on Consumer Safety can clear such substances as safe for cosmetics use, but prior to the group’s December opinion, it looked as if another preservative could be struck from industry’s toolkit.

Advertisement

Related Content

2018 In Review: Cosmetics Industry Mobilizes To Stop Preservatives Die-Off
CIR Tables Review Of Preservative PHMB; Industry Maintains Data Is On The Way
Cosmetic Preservatives Stand Better Chance In EU If CMR Bans Aren't 'Automatic'
EC's Non-Automatic Ban Policy For CMRs In Cosmetics 'Plainly Illegal' – NGOs
CIR: Industry Working On Producing Preservative PHMB Sensitization Data
CIR News In Brief: No Conclusion Reached On PHMB; Endocrine Activity Guidance; More
CIR Panel Needs Outside Expertise To Continue Parabens Re-Review
CIR Seeks More Information On Preservative PHMB
Cosmetics News In Brief: CIR Panel To Review Preservative; ICCR Prep; More
Preservative PHMB On Deck For Accelerated CIR Review

Topics

Advertisement
UsernamePublicRestriction

Register

RS109036

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel